Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Aplastic Anemia
NCT03055078Phase 1Unknown
- Sponsor
- Hebei Medical University
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of human umbilical cord mesenchymal stem cells in aplastic anemia (2 arms), sponsored by Hebei Medical University. Primary endpoint: Hemoglobin levels in peripheral blood at 9 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT03055078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055078.